ERYTHRA-DERM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Erythra-derm, and what generic alternatives are available?
Erythra-derm is a drug marketed by Micro Labs and is included in one NDA.
The generic ingredient in ERYTHRA-DERM is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Erythra-derm
A generic version of ERYTHRA-DERM was approved as erythromycin by TORRENT on July 6th, 2020.
Summary for ERYTHRA-DERM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Patent Applications: | 4,260 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ERYTHRA-DERM at DailyMed |
Pharmacology for ERYTHRA-DERM
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHRA-DERM
US Patents and Regulatory Information for ERYTHRA-DERM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Micro Labs | ERYTHRA-DERM | erythromycin | SOLUTION;TOPICAL | 062687-001 | Feb 5, 1988 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |